The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Translational Pipeline Program, 2023Using Sleep Modulation to Enhance the Brain’s Waste Clearance Mechanisms as an Approach to Limiting the Progression of Parkinson’s Disease
Study Rationale: Recent studies have demonstrated that the brains of people with Parkinson’s disease (PD) show a buildup of toxic proteins that is due to an impairment in the brain’s waste clearance...
-
Accelerating the Translation of Parkinson's Disease Therapies, 2023Evaluating Polyamines as Biomarkers for Parkinson’s Disease
Study Rationale: One of genes associated with Parkinson’s disease (PD), ATP13A2, regulates the levels of polyamines in the lysosome, an acidic compartment of the cell. Polyamines are neuroprotective...
-
Biomarkers to Support Therapeutic Trials Program, 2023Developing a Novel Platform for Patient Selection and Disease Tracking Using Super-resolution Microscopy and AI
Study Rationale: The ability to track alpha-synuclein pathology in tissues outside the brain would facilitate accurate diagnosis of Parkinson's disease (PD), enable inclusion of individuals with alpha...
-
Translational Pipeline Program, 2023Exploring the Use of Molecules that Stabilize the Interaction between LRRK2 Kinase and the 14-3-3 Adapter Protein as a Neuroprotective Therapy for Parkinson’s Disease
Study Rationale: Parkinson’s disease (PD) is associated with activating mutations in a protein kinase called LRRK2. In previous studies, we found that regulating LRRK2’s chemical modification by...
-
Research Grant, 2023A Novel Preclinical Candidate for Reducing Alpha-synuclein Aggregation in Parkinson’s Disease
Study Rationale: The goal of this program is to develop a novel drug for Parkinson’s disease (PD) with a unique mechanism of action. We have a drug candidate that shows potential as an inhibitor of...
-
Research Resources Imaging Program, 2023Development of Biomarkers Based on Brainstem Nuclei for Prodromal Parkinson's Disease
Study Rationale: Early diagnosis of Parkinson’s disease (PD) requires development of biomarkers that can be used to detect the first signs of neurodegeneration. Animal models suggest that tiny regions...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.